Dr. Palleja is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2 Redmond Ct
Bridgewater, NJ 08807Phone+1 908-218-0338
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 1980 - 1983
Boston University School of MedicineClass of 1980
Certifications & Licensure
NY State Medical License 1983 - 2026
Publications & Presentations
PubMed
- 54 citationsSafety, efficacy, and pharmacokinetics of TBR-652, a CCR5/CCR2 antagonist, in HIV-1-infected, treatment-experienced, CCR5 antagonist-naive subjects.Jacob Lalezari, Joseph Gathe, Cynthia Brinson, Melanie Thompson, Calvin J. Cohen
Journal of Acquired Immune Deficiency Syndromes. 2011-06-01 - 33 citationsPharmacokinetics and Pharmacodynamics of TBR-652, a Novel CCR5 Antagonist, in HIV-1-Infected, Antiretroviral Treatment-Experienced, CCR5 Antagonist-Naïve PatientsJean-Francois Marier, MyMy Trinh, Leng Hong Pheng, Sandra M. Palleja, David E. Martin
Antimicrobial Agents and Chemotherapy. 2011-06-01 - 6 citationsSafety and Pharmacokinetics of GSK364735, a Human Immunodeficiency Virus Type 1 Integrase Inhibitor, following Single and Repeated Administration in Healthy Adult Subj...Y. Sunila Reddy, Sherene S. Min, Julie Borland, Ivy Song, Jiang Lin
Antimicrobial Agents and Chemotherapy. 2007-12-01
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
